In more localized tests on each CpG locus within each promoter region, CpG at -63 of DAPK promoter and CpG at +52 of PAX5β promoter were significantly associated with lung cancer versus non-cancer controls (p = 0.0042 and 0.0093, respectively). Here, DAPK1 is linked to cancer.